Trial Profile
A phase 2, double-blind, randomized, safety and efficacy study of GE-145 versus Iohexol in subjects undergoing coronary angiography.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Ioforminol (Primary) ; Iohexol
- Indications Coronary artery disease
- Focus Diagnostic use
- Sponsors Daiichi Sankyo Company
- 30 May 2014 New trial record